Opko Health OPK
NASDAQ OPK
$1.71 +0.02 (+1.18%)
As of: Sep 22, 2026 · 10:48 AM EDT

Opko Health (OPK) Common Equity (2010 - 2026)

Opko Health's (OPK) quarterly Common Equity came in at $1.2 billion in Q2 2026, down 8.69% on a YoY basis from $1.3 billion in Q2 2025, and down 1.7% quarter-over-quarter from $1.2 billion in Q1 2026.

Analysis

Opko Health (OPK) Common Equity (2010 - 2026) Analysis & Trends

Opko Health (OPK) has reported Common Equity for 17 consecutive years, with $1.2 billion the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Common Equity fell 8.69% year-over-year to $1.2 billion; the trailing twelve-month figure through Jun 2026 stood at $1.2 billion (down 8.69% YoY), and the FY2025 full-year result was $1.3 billion, down 7.14% from the prior year.
  • Common Equity slipped to $1.2 billion in Q2 2026 per OPK's latest filing, from $1.2 billion in the prior quarter.
  • Across five years, Common Equity topped out at $1.7 billion in Q2 2022 and bottomed at $1.2 billion in Q2 2026.
  • Historically, Common Equity has averaged $1.4 billion across 5 years, with a median of $1.4 billion in 2023.
  • The sharpest annual moves came in 2024 and 2025: Common Equity slipped 19.27% in 2024, then gained 4.7% in 2025.
  • Over 5 years, Common Equity stood at $1.6 billion in 2022, then decreased by 11.04% to $1.4 billion in 2023, then retreated by 1.71% to $1.4 billion in 2024, then fell by 7.14% to $1.3 billion in 2025, then declined by 6.61% to $1.2 billion in 2026.
  • According to Business Quant data, Common Equity over the past three periods registered $1.2 billion, $1.2 billion, and $1.3 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Common Equity (Qtr)
1 Johnson & Johnson 650.65 Bn 629.89 Bn 17.26 Bn 84.97 Bn
2 AbbVie 466.34 Bn 459.82 Bn 12.70 Bn -5.94 Bn
3 Merck 362.11 Bn 355.02 Bn 12.21 Bn 106.07 Bn
4 Novartis Ag 267.81 Bn 260.52 Bn 11.24 Bn 41.95 Bn
5 Pfizer 157.31 Bn 145.91 Bn 10.94 Bn 85.49 Bn
6 Bristol Myers Squibb 128.75 Bn 117.69 Bn 9.25 Bn 22.32 Bn
7 Sanofi 51.80 Bn 44.84 Bn 10.79 Bn 80.86 Bn
8 Revolution Medicines 40.91 Bn 40.91 Bn - 2.61 Bn
9 BeOne Medicines 39.65 Bn 34.55 Bn 1.53 Bn 5.17 Bn
10 Opko Health 1.25 Bn 945.61 Mn 80.02 Mn 1.18 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.18 Bn
Mar 31, 2026 1.20 Bn
Dec 31, 2025 1.27 Bn
Sep 30, 2025 1.31 Bn
Jun 30, 2025 1.30 Bn
Mar 31, 2025 1.31 Bn
Dec 31, 2024 1.37 Bn
Sep 30, 2024 1.40 Bn
Jun 30, 2024 1.40 Bn
Mar 31, 2024 1.25 Bn
Dec 31, 2023 1.39 Bn
Sep 30, 2023 1.44 Bn
Jun 30, 2023 1.54 Bn
Mar 31, 2023 1.55 Bn
Dec 31, 2022 1.56 Bn
Sep 30, 2022 1.63 Bn
Jun 30, 2022 1.72 Bn
Mar 31, 2022 1.61 Bn
Dec 31, 2021 1.69 Bn
Sep 30, 2021 1.77 Bn
API Access

Opko Health Common Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=common-equity&ticker=OPK&period=max&api_key=YOUR_API_KEY